We are live on ! Find out more
KCM

Kornitzer Capital Management Portfolio holdings

AUM $4.79B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+30.56%
3 Year Est. Return
+78.14%
5 Year Est. Return
+100.44%
10 Year Est. Return
+507.87%
AUM
$9.35B
AUM Growth
+$793M
Cap. Flow
-$105M
Cap. Flow %
-1.12%
Top 10 Hldgs %
16.53%
Holding
448
New
28
Increased
157
Reduced
161
Closed
21

Top Buys

Rank Stock Value
1
RH icon
RH
RH
+$63.6M
2
PRLB icon
Protolabs
PRLB
+$40.6M
3
EQIX icon
Equinix
EQIX
+$29.3M
4
LGF
Lions Gate Entertainment
LGF
+$29.3M
5
GTLS
Chart Industries
GTLS
+$26.5M

Sector Composition

Rank Sector Weight
1 Technology 20.18%
2 Industrials 15.44%
3 Healthcare 12.95%
4 Consumer Discretionary 11.32%
5 Financials 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAY
276
DELISTED
BAYER AG SPONS ADR
BAY
$3.56M 0.04%
25,332
-525
-2% -$73.8K
SAP icon
277
SAP
SAP
$249B
$3.51M 0.04%
40,300
+2,000
+5% +$159K
EXA
278
DELISTED
EXA Corporation
EXA
$3.5M 0.04%
263,700
+91,000
+53% +$1.32M
RIO icon
279
Rio Tinto
RIO
$158B
$3.45M 0.04%
61,110
-100,550
-62% -$5.23M
VLP
280
DELISTED
Valero Energy Partners LP
VLP
$3.44M 0.04%
+100,000
New +$3.01M
ABBV icon
281
AbbVie
ABBV
$465B
$3.44M 0.04%
65,133
+483
+0.7% +$23.7K
UN
282
DELISTED
Unilever NV New York Registry Shares
UN
$3.38M 0.04%
83,884
+26,050
+45% +$1.01M
XYL icon
283
Xylem
XYL
$25.1B
$3.37M 0.04%
97,410
-3,800
-4% -$122K
AGIO icon
284
Agios Pharmaceuticals
AGIO
$1.96B
$3.35M 0.04%
139,900
+30,700
+28% +$700K
MPLX icon
285
MPLX
MPLX
$59.2B
$3.34M 0.04%
75,000
TSM icon
286
TSMC
TSM
$2.15T
$3.17M 0.03%
181,631
+25,000
+16% +$444K
RDY icon
287
Dr. Reddy's Laboratories
RDY
$9.62B
$3.08M 0.03%
375,000
+89,500
+31% +$708K
ERIC icon
288
Ericsson
ERIC
$32.8B
$3.05M 0.03%
249,000
+60,000
+32% +$746K
OXFD
289
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$2.96M 0.03%
+152,612
New +$2.7M
CSX icon
290
CSX Corp
CSX
$90.1B
$2.91M 0.03%
303,300
EXC icon
291
Exelon
EXC
$43.5B
$2.9M 0.03%
148,332
-15,352
-9% -$309K
XLS
292
DELISTED
EXELIS INC COM STK
XLS
$2.9M 0.03%
162,712
-28,890
-15% -$460K
TEVA icon
293
Teva Pharmaceuticals
TEVA
$45.7B
$2.89M 0.03%
72,200
+56,495
+360% +$2.22M
NOV icon
294
NOV
NOV
$7.48B
$2.88M 0.03%
40,168
-2,185
-5% -$159K
RIG icon
295
Transocean
RIG
$6.63B
$2.69M 0.03%
+54,390
New +$2.66M
ABEV icon
296
Ambev
ABEV
$46.6B
$2.66M 0.03%
+361,500
New +$2.64M
CCU icon
297
Compañía de Cervecerías Unidas
CCU
$2.09B
$2.65M 0.03%
109,688
+31,688
+41% +$803K
FMI
298
DELISTED
Foundation Medicine, Inc.
FMI
$2.62M 0.03%
110,000
+70,000
+175% +$1.96M
GWRE icon
299
Guidewire Software
GWRE
$12.4B
$2.59M 0.03%
52,800
AVGO icon
300
Broadcom
AVGO
$1.62T
$2.58M 0.03%
487,700
+40,000
+9% +$184K

Similar funds

Kornitzer Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Kornitzer Capital Management held 448 positions worth $9.35B, up 9.3% from $8.55B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Kornitzer Capital Management's Q4 2013 filing shows 28 new, 157 increased, 161 reduced and 21 closed positions. Its largest new stake was RH: 927,958 shares worth $62.5M. The largest sale was Harman International Industries, an estimated $93.8M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Industrials and Healthcare.

  • Kornitzer Capital Management's largest Q4 2013 buy was RH: 927,958 shares worth $62.5M.
  • Kornitzer Capital Management added most to Protolabs in Q4 2013, an estimated $40.6M increase.
  • Kornitzer Capital Management's biggest Q4 2013 reduction was Harman International Industries, cutting an estimated $93.8M.
  • Kornitzer Capital Management fully exited Valmont Industries in Q4 2013, selling an estimated $55.1M.
  • Kornitzer Capital Management's ten largest holdings make up 17% of its $9.35B portfolio in Q4 2013.
  • Kornitzer Capital Management opened 28 new positions and closed 21 in Q4 2013.
  • Kornitzer Capital Management's portfolio value rose 9.3% quarter-over-quarter to $9.35B.

Based on Kornitzer Capital Management's 13F filing for Q4 2013, filed 6 Feb 2014.